Susquehanna International Group’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $8.79M | Buy |
1,869,615
+888,017
| +90% | +$4.51M | 0.01% | 3310 |
|
|
2025
Q4 | $4.18M | Buy |
981,598
+714,113
| +267% | +$2.71M | 0.01% | 4308 |
|
|
2025
Q3 | $853K | Sell |
267,485
-24,411
| -8% | -$55K | ﹤0.01% | 7713 |
|
|
2025
Q2 | $663K | Buy |
291,896
+263,162
| +916% | +$424K | ﹤0.01% | 8510 |
|
|
2025
Q1 | $18.3K | Sell |
28,734
-31,044
| -52% | -$24.1K | ﹤0.01% | 12129 |
|
|
2024
Q4 | $61.6K | Buy |
59,778
+49,474
| +480% | +$53.2K | ﹤0.01% | 11591 |
|
|
2024
Q3 | $12.2K | Sell |
10,304
-15,615
| -60% | -$19.8K | ﹤0.01% | 11699 |
|
|
2024
Q2 | $31.6K | Sell |
25,919
-910,859
| -97% | -$1.81M | ﹤0.01% | 11548 |
|
|
2024
Q1 | $2.04M | Buy |
936,778
+897,786
| +2,302% | +$1.66M | ﹤0.01% | 5286 |
|
|
2023
Q4 | $60.4K | Sell |
38,992
-49,578
| -56% | -$65.2K | ﹤0.01% | 11635 |
|
|
2023
Q3 | $114K | Sell |
88,570
-1,672
| -2% | -$2.63K | ﹤0.01% | 10808 |
|
|
2023
Q2 | $155K | Sell |
90,242
-257,544
| -74% | -$428K | ﹤0.01% | 10544 |
|
|
2023
Q1 | $525K | Buy |
347,786
+334,618
| +2,541% | +$756K | ﹤0.01% | 8442 |
|
|
2022
Q4 | $21.1K | Sell |
13,168
-82
| -0.6% | -$121 | ﹤0.01% | 11748 |
|
|
2022
Q3 | $19K | Sell |
13,250
-23,475
| -64% | -$36.1K | ﹤0.01% | 12615 |
|
|
2022
Q2 | $67K | Sell |
36,725
-45,076
| -55% | -$86.3K | ﹤0.01% | 11793 |
|
|
2022
Q1 | $218K | Sell |
81,801
-44,902
| -35% | -$172K | ﹤0.01% | 11027 |
|
|
2021
Q4 | $549K | Buy |
126,703
+5,017
| +4% | +$29.4K | ﹤0.01% | 8931 |
|
|
2021
Q3 | $620K | Buy |
121,686
+12,420
| +11% | +$66.5K | ﹤0.01% | 8834 |
|
|
2021
Q2 | $692K | Sell |
109,266
-18,192
| -14% | -$142K | ﹤0.01% | 8770 |
|
|
2021
Q1 | $985K | Buy |
127,458
+113,099
| +788% | +$895K | ﹤0.01% | 7779 |
|
|
2020
Q4 | $94K | Sell |
14,359
-9,465
| -40% | -$67.6K | ﹤0.01% | 10520 |
|
|
2020
Q3 | $158K | Sell |
23,824
-2,747
| -10% | -$20.4K | ﹤0.01% | 9647 |
|
|
2020
Q2 | $221K | Buy |
26,571
+6,719
| +34% | +$62.4K | ﹤0.01% | 8867 |
|
|
2020
Q1 | $152K | Buy |
19,852
+4,234
| +27% | +$29.5K | ﹤0.01% | 8979 |
|
|
2019
Q4 | $130K | Sell |
15,618
-13,297
| -46% | -$89.7K | ﹤0.01% | 9018 |
|
|
2019
Q3 | $213K | Sell |
28,915
-18,544
| -39% | -$183K | ﹤0.01% | 8978 |
|
|
2019
Q2 | $532K | Buy |
+47,459
| New | +$498K | ﹤0.01% | 7132 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 9119 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 9224 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 9484 |
|
|
2018
Q2 | – | Hold |
0
| – | – | – | 9817 |
|
|
2017
Q1 | – | Sell |
-33,186
| Closed | -$365K | – | 9126 |
|
|
2016
Q4 | $365K | Buy |
+33,186
| New | +$402K | ﹤0.01% | 7598 |
|
|
2016
Q1 | – | Sell |
-23,222
| Closed | -$485K | – | 9112 |
|
|
2015
Q4 | $485K | Buy |
+23,222
| New | +$367K | ﹤0.01% | 6820 |
|
Other funds holding CTMX
KCM
PA
VA
VCM
